Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
| $220M | 0.07% |
4,168,114
-2,290,188
| -35% | -$120M |
|
302
Pinnacle West Capital
PNW
$12.9B
| $219M | 0.07% |
2,917,537
+1,284,112
| +79% | +$87.8M |
|
303
Estee Lauder
EL
$30.7B
| $219M | 0.07% |
2,320,753
-328,662
| -12% | -$29.3M |
|
304
Brixmor Property Group
BRX
$9.94B
| $219M | 0.07% |
8,535,739
-1,794,849
| -17% | -$44.2M |
|
|
PARA
305
DELISTED
Paramount Global Class B
PARA
| $219M | 0.07% |
3,968,798
-636,912
| -14% | -$31M |
|
306
Teva Pharmaceuticals
TEVA
$36.6B
| $218M | 0.07% |
4,080,416
-919,546
| -18% | -$54M |
|
307
LyondellBasell Industries
LYB
$19B
| $217M | 0.07% |
2,540,224
-272,200
| -10% | -$21.8M |
|
|
OKS
308
DELISTED
Oneok Partners LP
OKS
| $217M | 0.07% |
6,922,903
-1,465,537
| -17% | -$41.3M |
|
309
PUT
Tesla
TSLA
$1.21T
| $215M | 0.07% |
14,041,500
-1,135,500
| -7% | -$14.9M |
|
310
Dominion Energy
D
$62.3B
| $215M | 0.07% |
2,858,479
+741,107
| +35% | +$52.4M |
|
311
YPF
YPF
$19.5B
| $215M | 0.07% |
12,007,532
-287,345
| -2% | -$4.76M |
|
|
CVC
312
DELISTED
CABLEVISION SYS CP NY GRP CL-A
CVC
| $215M | 0.07% |
6,505,399
+3,491,570
| +116% | +$113M |
|
313
Lam Research
LRCX
$336B
| $214M | 0.07% |
25,867,380
+9,123,960
| +54% | +$66.4M |
|
314
Stanley Black & Decker
SWK
$14.5B
| $213M | 0.07% |
2,027,750
+704,521
| +53% | +$68.4M |
|
315
Eli Lilly
LLY
$1.09T
| $213M | 0.07% |
2,961,112
-702,879
| -19% | -$53.2M |
|
|
WES
316
DELISTED
Western Gas Partners Lp
WES
| $213M | 0.07% |
4,900,934
+1,218,204
| +33% | +$45M |
|
317
Vanguard Real Estate ETF
VNQ
$40.2B
| $211M | 0.07% |
2,521,917
+233,314
| +10% | +$18.2M |
|
|
VXX
318
PUT
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
| $211M | 0.07% |
749,044
+70,413
| +10% | +$26.5M |
|
319
PayPal
PYPL
$51.8B
| $210M | 0.07% |
5,451,943
-660,021
| -11% | -$23.8M |
|
320
Air Products & Chemicals
APD
$65.6B
| $209M | 0.07% |
1,571,347
+934,224
| +147% | +$113M |
|
321
Genesis Energy
GEL
$1.81B
| $209M | 0.07% |
6,574,013
-537,702
| -8% | -$14.9M |
|
|
NFX
322
DELISTED
Newfield Exploration
NFX
| $209M | 0.07% |
6,274,359
+2,350,496
| +60% | +$66.3M |
|
323
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.43B
| $208M | 0.07% |
1,716,742
-159,150
| -8% | -$17.2M |
|
|
BNFT
324
DELISTED
Benefitfocus, Inc.
BNFT
| $208M | 0.07% |
6,242,946
| – | – |
|
325
CALL
AT&T
T
$170B
| $208M | 0.07% |
7,029,910
+2,960,800
| +73% | +$82M |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.